(Q53912448)

English

TRANCE-RANK Costimulation is Required for IL-12 Production and the Initiation of a Th1-Type Response toLeishmania majorInfection in CD40L-Deficient Mice

scientific article published on November 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

TRANCE-RANK Costimulation is Required for IL-12 Production and the Initiation of a Th1-Type Response toLeishmania majorInfection in CD40L-Deficient Mice (English)

reason for preferred rank

most precise value

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607948

30 March 2024

Leishmania major

object named as

Leishmania major

1 reference

based on heuristic

inferred from title

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

author name string

Nacksung Kim

2

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

Yongwon Choi

3

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

Udaikumar M. Padigel

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607948

30 March 2024

Jay P. Farrell

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14607948

30 March 2024

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

15 November 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14607948

30 March 2024

full work available at URL

Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

171

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

10

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

5437-5441

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

CD4+ T cell subsets in experimental cutaneous leishmaniasis

1

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

2

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets

3

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.

4

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response

7

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Recombinant interleukin 12 cures mice infected with Leishmania major

8

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

IL-12 is required to maintain a Th1 response during Leishmania major infection.

9

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge

10

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

The role of IL-12 in maintaining resistance to Leishmania major.

11

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

12

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Leishmania promastigotes evade interleukin 12 (IL-12) induction by macrophages and stimulate a broad range of cytokines from CD4+ T cells during initiation of infection

13

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice

14

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity

15

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Dendritic cells, but not macrophages, produce IL-12 immediately followingLeishmania donovani infection

16

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Murine dendritic cells internalize Leishmania major promastigotes, produce IL-12 p40 and stimulate primary T cell proliferation in vitro.

17

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Preformed membrane-associated stores of interleukin (IL)-12 are a previously unrecognized source of bioactive IL-12 that is mobilized within minutes of contact with an intracellular parasite

18

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Leishmania priming of human dendritic cells for CD40 ligand-induced interleukin-12p70 secretion is strain and species dependent

19

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process

20

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity

21

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

CD40 ligand is required for protective cell-mediated immunity to Leishmania major

22

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

23

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Underproduction of interleukin-12 in susceptible mice during progressive leishmaniasis is due to decreased CD40 activity

24

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

The development of a Th1-type response and resistance to Leishmania major infection in the absence of CD40-CD40L costimulation

25

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

CD40-CD40 ligand costimulation is not required for initiation and maintenance of a Th1-type response to Leishmania major infection

26

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

RANK-L and RANK: T cells, bone loss, and mammalian evolution

27

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Identification of an infective stage of Leishmania promastigotes.

29

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

The adjuvant effect of interleukin-12 in a vaccine against Leishmania major.

30

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

31

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Depletion of interleukin-4 in BALB/c mice with established Leishmania major infections increases the efficacy of antimony therapy and promotes Th1-like responses

32

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

In vivo alterations in cytokine production following interleukin-12 (IL-12) and anti-IL-4 antibody treatment of CB6F1 mice with chronic cutaneous leishmaniasis.

33

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Toll-like receptors and innate immunity

35

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

37

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

TRANCE, a tumor necrosis factor family member critical for CD40 ligand-independent T helper cell activation

38

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Interferon-gamma directly inhibits TRANCE-induced osteoclastogenesis

39

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Suppression of IL-12 production by soluble CD40 ligand: evidence for involvement of the p44/42 mitogen-activated protein kinase pathway

40

1 reference

10.4049/JIMMUNOL.171.10.5437

https://api.crossref.org/works/10.4049/JIMMUNOL.171.10.5437

30 March 2024

Identifiers

10.4049/JIMMUNOL.171.10.5437

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14607948

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53912448&oldid=2117780458"